Movie S1.

Clinical score and movement monitoring of cyclotide-treated mice. [T20K]kB1, [V10K]kB1, and control EAE mice were monitored during scoring (Fig. 2A). The mouse treated with [T20K]kB1 is labeled with a red tag and the one that received [V10K]kB1 with a white tag. The untreated control mouse is unlabeled. The [T20K]kB1 mouse shows a healthy behavior, meaning score 0, which is defined by the ability to move the tail tip. In comparison the [V10K]kB1 and control EAE mice demonstrated a shambling walk induced by the initiating paraparesis, also assured by the tail paralysis, characterizing a score of ~1.5.

Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis

Kathrin Thell, Roland Hellinger, Emine Sahin, Paul Michenthaler, Markus Gold-Binder, Thomas Haider, Mario Kuttke, Zita Liutkevičiūtė, Ulf Göransson, Carsten Gründemann, Gernot Schabbauer, and Christian W. Gruber

PNAS. 2016. DOI: 10.1073/pnas.1519960113